BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 35175447)

  • 1. Persistent enlargement of the pancreatic gland after glucocorticoid therapy increases the risk of relapse in IgG4-related autoimmune pancreatitis.
    Lu H; Peng L; Zhu L; Feng R; Zhou J; Liu Z; Li J; Luo X; Peng Y; Qin C; Fei Y; Zhao Y; Zeng X; Lai Y; Zhang W
    Clin Rheumatol; 2022 Jun; 41(6):1709-1718. PubMed ID: 35175447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics and outcome of autoimmune pancreatitis based on serum immunoglobulin G4 level: A single-center, retrospective cohort study.
    Zhou GZ; Zeng JQ; Wang L; Liu M; Meng K; Wang ZK; Zhang XL; Peng LH; Yan B; Pan F
    World J Gastroenterol; 2023 Sep; 29(35):5125-5137. PubMed ID: 37744294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of Clinical, Serological, and Imaging Features of Autoimmune Pancreatitis and a Case-Control Study on Prognostic Factors in Response to Hormone Therapy.
    Liu Z; Zhu K; Sun C; Shen Y; Qu S
    Contrast Media Mol Imaging; 2022; 2022():4829467. PubMed ID: 35854780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcome of autoimmune pancreatitis after oral prednisolone therapy.
    Nishino T; Toki F; Oyama H; Shimizu K; Shiratori K
    Intern Med; 2006; 45(8):497-501. PubMed ID: 16702740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between pancreatic atrophy after steroid therapy and diabetes mellitus in patients with autoimmune pancreatitis.
    Masuda A; Shiomi H; Matsuda T; Takenaka M; Arisaka Y; Azuma T; Kutsumi H
    Pancreatology; 2014; 14(5):361-5. PubMed ID: 25278305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum IgG4-negative autoimmune pancreatitis.
    Kamisawa T; Takuma K; Tabata T; Inaba Y; Egawa N; Tsuruta K; Hishima T; Sasaki T; Itoi T
    J Gastroenterol; 2011 Jan; 46(1):108-16. PubMed ID: 20824290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and pathological differences between serum immunoglobulin G4-positive and -negative type 1 autoimmune pancreatitis.
    Paik WH; Ryu JK; Park JM; Song BJ; Park JK; Kim YT; Lee K
    World J Gastroenterol; 2013 Jul; 19(25):4031-8. PubMed ID: 23840149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreaticobiliary involvement in treated type 1 autoimmune pancreatitis: Imaging pattern and risk factors for disease relapse.
    Zhu L; Xue HD; Zhang W; Wang Q; Tan B; Lai YM; Zheng WY; Asbach P; Hamm B; Denecke T; Jin ZY
    Eur J Radiol; 2019 Nov; 120():108673. PubMed ID: 31550640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relapse rate and predictors of relapse in a large single center cohort of type 1 autoimmune pancreatitis: long-term follow-up results after steroid therapy with short-duration maintenance treatment.
    Lee HW; Moon SH; Kim MH; Cho DH; Jun JH; Nam K; Song TJ; Park DH; Lee SS; Seo DW; Lee SK
    J Gastroenterol; 2018 Aug; 53(8):967-977. PubMed ID: 29362937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors predictive of relapse and spontaneous remission of autoimmune pancreatitis patients treated/not treated with corticosteroids.
    Kubota K; Watanabe S; Uchiyama T; Kato S; Sekino Y; Suzuki K; Mawatari H; Iida H; Endo H; Fujita K; Yoneda M; Takahashi H; Kirikoshi H; Kobayashi N; Saito S; Sugimori K; Hisatomi K; Matsuhashi N; Sato H; Tanida E; Sakaguchi T; Fujisawa N; Nakajima A
    J Gastroenterol; 2011 Jun; 46(6):834-42. PubMed ID: 21491208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical factors predictive of spontaneous remission or relapse in cases of autoimmune pancreatitis.
    Kubota K; Iida H; Fujisawa T; Yoneda M; Inamori M; Abe Y; Kirikoshi H; Saito S; Ohshiro H; Kakuta Y; Nakajima A
    Gastrointest Endosc; 2007 Dec; 66(6):1142-51. PubMed ID: 18061714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmune pancreatitis: a systemic immune complex mediated disease.
    Deshpande V; Chicano S; Finkelberg D; Selig MK; Mino-Kenudson M; Brugge WR; Colvin RB; Lauwers GY
    Am J Surg Pathol; 2006 Dec; 30(12):1537-45. PubMed ID: 17122509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A diagnostic strategy to distinguish autoimmune pancreatitis from pancreatic cancer.
    Chari ST; Takahashi N; Levy MJ; Smyrk TC; Clain JE; Pearson RK; Petersen BT; Topazian MA; Vege SS
    Clin Gastroenterol Hepatol; 2009 Oct; 7(10):1097-103. PubMed ID: 19410017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Native T1 mapping of autoimmune pancreatitis as a quantitative outcome surrogate.
    Zhu L; Lai Y; Makowski M; Zhang W; Sun Z; Qian T; Nickel D; Hamm B; Asbach P; Duebgen M; Xue H; Jin Z
    Eur Radiol; 2019 Aug; 29(8):4436-4446. PubMed ID: 30707275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is autoimmune pancreatitis a risk factor for pancreatic adenocarcinoma?
    Kunovský L; Dítě P; Blaho M; Dvořáčková J; Uvírová M; Přecechtělová M; Jabandžiev P; Mašková H; Kianička B; Janeček P; Eid M; Martínek A
    Vnitr Lek; 2021; 67(1):9-13. PubMed ID: 33752395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical study of autoimmune pancreatitis using anti-IgG4 antibody and patients' sera.
    Aoki S; Nakazawa T; Ohara H; Sano H; Nakao H; Joh T; Murase T; Eimoto T; Itoh M
    Histopathology; 2005 Aug; 47(2):147-58. PubMed ID: 16045775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical observation of isolated immunoglobulin G4-related sclerosing cholangitis and immunoglobulin G4 sclerosing cholangitis combined autoimmune pancreatitis].
    Jiang P; Lian M; Li B; Xiao X; Miao Q; Wang QX; Ma X
    Zhonghua Gan Zang Bing Za Zhi; 2018 Jun; 26(6):415-419. PubMed ID: 30317753
    [No Abstract]   [Full Text] [Related]  

  • 18. Autoimmune pancreatitis: Cornerstones and future perspectives.
    Gallo C; Dispinzieri G; Zucchini N; Invernizzi P; Massironi S
    World J Gastroenterol; 2024 Feb; 30(8):817-832. PubMed ID: 38516247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of immunoglobulin g4 immunostaining in diagnosing pancreatic and extrapancreatic involvement in autoimmune pancreatitis.
    Deheragoda MG; Church NI; Rodriguez-Justo M; Munson P; Sandanayake N; Seward EW; Miller K; Novelli M; Hatfield AR; Pereira SP; Webster GJ
    Clin Gastroenterol Hepatol; 2007 Oct; 5(10):1229-34. PubMed ID: 17702660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly active state of autoimmune pancreatitis with mikulicz disease.
    Kubota K; Wada T; Kato S; Mozaki Y; Yoneda M; Fujita K; Takahashi H; Inamori M; Abe Y; Kobayashi N; Kirikoshi H; Saito S; Inayama Y; Nakajima A
    Pancreas; 2010 Jan; 39(1):e6-10. PubMed ID: 19904224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.